<qa>  What is the STUDY OF ASP2215 VERSUS SALVAGE CHEA STUDY OF ASP2215 VERSUS SALVAGE CHEMOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA AML WITH FMS-LIKE TYROSINE KINASE FLT3 MUTATION: 